Comparing mCRC Therapies: FTD/TPI Plus Bevacizumab, Fruquintinib, and Regorafenib

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

A study from Sweden, the largest of its kind, challenges the standard 24-month milestone as the key point when early relapse is a concern.

December 23rd 2025

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

Debates at the International Stroke Conference 2026 centered on optimal treatment of ischemic stroke in the modern era. | Image credit: Aliaksandr Marko - stock.adobe.com

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

In a pair of lively debates at the International Stroke Conference 2026, experts from around the world discussed controversies in stroke care.

November 25th 2025

Serial CT Response Score Predicts OS in Patients With Advanced NSCLC Receiving ICIs

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

CT lung scans | Image Credit: Peakstock - stock.adobe.com

February 5th 2026

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

City St. George’s researcher Ateequllah Hayat, PhD, explains newly identified mechanisms behind lapatinib resistance in HER2-positive breast cancer.

February 4th 2026

Even After 6 Years, Disease Progression Impacts Survival in Mantle Cell Lymphoma

Ateequllah Hayat, PhD, discusses epigenetic rewiring, biomarkers, and emerging strategies to overcome lapatinib resistance in HER2+ breast cancer.

Related Content

Switching From MA to TM Increases Mental Health Care Use: Angela Liu, PhD, MPH

A study from Sweden, the largest of its kind, challenges the standard 24-month milestone as the key point when early relapse is a concern.

December 23rd 2025

Is Less More After Thrombolysis? Debating Intensive Stroke Monitoring at ISC 2026

Angela Liu, PhD, MPH, speaks about her study that examined mental health care use by Medicare beneficiaries before and after switching from MA to TM.

Listen

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

In a pair of lively debates at the International Stroke Conference 2026, experts from around the world discussed controversies in stroke care.

November 25th 2025

Serial CT Response Score Predicts OS in Patients With Advanced NSCLC Receiving ICIs

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

February 5th 2026

New Molecular Drivers of HER2 Breast Cancer Resistance: A Q&A With Ateequllah Hayat, PhD

A deep-learning serial CT response score outperformed conventional imaging measures in predicting OS for patients with advanced NSCLC treated with ICIs.

February 4th 2026